- Home
- OCCI vs RPTX Comparison
OCCI vs RPTX Comparison
Compare OCCI & RPTX Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
- Machine Learning Prediction
- ML Decision
- OCCI
- RPTX
- Stock Information
- Founded
- OCCI N/A
- RPTX 2016
- Country
- OCCI United States
- RPTX Canada
- Employees
- OCCI N/A
- RPTX N/A
- Industry
- OCCI Trusts Except Educational Religious and Charitable
- RPTX Biotechnology: Pharmaceutical Preparations
- Sector
- OCCI Finance
- RPTX Health Care
- Exchange
- OCCI Nasdaq
- RPTX Nasdaq
- Market Cap
- OCCI 123.6M
- RPTX 119.7M
- IPO Year
- OCCI N/A
- RPTX 2020
- Fundamental
- Price
- OCCI $7.44
- RPTX $3.46
- Analyst Decision
- OCCI
- RPTX Strong Buy
- Analyst Count
- OCCI 0
- RPTX 3
- Target Price
- OCCI N/A
- RPTX $17.33
- AVG Volume (30 Days)
- OCCI 115.8K
- RPTX 146.0K
- Earning Date
- OCCI 12-11-2023
- RPTX 11-07-2024
- Dividend Yield
- OCCI 24.32%
- RPTX N/A
- EPS Growth
- OCCI N/A
- RPTX N/A
- EPS
- OCCI N/A
- RPTX N/A
- Revenue
- OCCI N/A
- RPTX $68,683,000.00
- Revenue This Year
- OCCI N/A
- RPTX $16.85
- Revenue Next Year
- OCCI $10.19
- RPTX N/A
- P/E Ratio
- OCCI N/A
- RPTX N/A
- Revenue Growth
- OCCI N/A
- RPTX N/A
- 52 Week Low
- OCCI $5.47
- RPTX $2.71
- 52 Week High
- OCCI $10.15
- RPTX $8.84
- Technical
- Relative Strength Index (RSI)
- OCCI 47.49
- RPTX 58.46
- Support Level
- OCCI $7.34
- RPTX $3.34
- Resistance Level
- OCCI $7.55
- RPTX $3.72
- Average True Range (ATR)
- OCCI 0.13
- RPTX 0.20
- MACD
- OCCI -0.03
- RPTX 0.02
- Stochastic Oscillator
- OCCI 26.92
- RPTX 61.19
About OCCI OFS Credit Company Inc.
OFS Credit Co Inc is a non-diversified, closed-end management investment company. Its investment objective is to generate current income, with a secondary objective to generate capital appreciation. The company invests in floating rate credit instruments and other structured credit investments, including; collateralized loan obligation (CLO) debt and subordinated (i.e., residual or equity) securities; traditional corporate credit investments, including leveraged loans and high yield bonds; opportunistic credit investments, including stressed and distressed credit situations and long/short credit investments; and other credit-related instruments.
About RPTX Repare Therapeutics Inc.
Repare Therapeutics Inc is a precision medicine oncology company focused on the development of synthetic lethality-based therapies for patients with cancer. The Company's focus is the research, development and commercialization of precision oncology drugs targeting specific vulnerabilities of tumors in genetically defined patient populations. The company derives maximum revenue from Canada.